| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.05 |